KSA
CELG

Ken Stern & Associates’s Celgene Corp CELG Stock Holding History

Ken Stern & Associates’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$242K Buy
+2,707
New +$239K 0.11% 125
2018
Q2 		– Sell
-2,728
Closed -$243K – 134
2018
Q1 		$243K Buy
+2,728
New +$262K 0.11% 109
2015
Q1 		– Sell
-10,956
Closed -$1.23M – 100
2014
Q4 		$1.23M Buy
+10,956
New +$1.16M 0.95% 26

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ken Stern & Associates's CELG Position: Q3 2018 in Review

Ken Stern & Associates opened a new position in Celgene Corp (CELG) in Q3 2018: 2,707 shares worth $242K. The stake represents 0.11% of the portfolio and ranks #125 among its holdings. This is a return to the name: Ken Stern & Associates previously reported a position in CELG as recently as Q1 2018.

Ken Stern & Associates first reported a position in CELG in Q4 2014 and has held it in 3 quarters since. The position peaked at $1.23M in Q4 2014. 1,364 funds tracked by Wall St. Rank hold CELG as of Q3 2018.

  • Ken Stern & Associates held 2,707 shares of Celgene Corp worth $242K as of Q3 2018.
  • Celgene Corp was a new Ken Stern & Associates position in Q3 2018.
  • Celgene Corp made up 0.11% of Ken Stern & Associates's portfolio in Q3 2018, its #125 holding.
  • Ken Stern & Associates first reported a position in Celgene Corp in Q4 2014 and has held it in 3 quarters since.
  • Ken Stern & Associates's Celgene Corp position peaked at $1.23M in Q4 2014.
  • 1,364 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2018.

Based on Ken Stern & Associates's 13F filing for Q3 2018, filed 13 Nov 2018.